Cargando…

Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data

BACKGROUND: There is a pressing need to understand better the extent and distribution of antimicrobial resistance on a global scale, to inform development of effective interventions. Collation of datasets for meta-analysis, mathematical modelling and temporo-spatial analysis is hampered by the consi...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Paul, Fox-Lewis, Andrew, Shrestha, Poojan, Dance, David A. B., Wangrangsimakul, Tri, Cusack, Tomas-Paul, Ling, Clare L., Hopkins, Jill, Roberts, Tamalee, Limmathurotsakul, Direk, Cooper, Ben S., Dunachie, Susanna, Moore, Catrin E., Dolecek, Christiane, van Doorn, H. Rogier, Guerin, Philippe J., Day, Nicholas P. J., Ashley, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440102/
https://www.ncbi.nlm.nih.gov/pubmed/30922309
http://dx.doi.org/10.1186/s12916-019-1301-1
_version_ 1783407332702552064
author Turner, Paul
Fox-Lewis, Andrew
Shrestha, Poojan
Dance, David A. B.
Wangrangsimakul, Tri
Cusack, Tomas-Paul
Ling, Clare L.
Hopkins, Jill
Roberts, Tamalee
Limmathurotsakul, Direk
Cooper, Ben S.
Dunachie, Susanna
Moore, Catrin E.
Dolecek, Christiane
van Doorn, H. Rogier
Guerin, Philippe J.
Day, Nicholas P. J.
Ashley, Elizabeth A.
author_facet Turner, Paul
Fox-Lewis, Andrew
Shrestha, Poojan
Dance, David A. B.
Wangrangsimakul, Tri
Cusack, Tomas-Paul
Ling, Clare L.
Hopkins, Jill
Roberts, Tamalee
Limmathurotsakul, Direk
Cooper, Ben S.
Dunachie, Susanna
Moore, Catrin E.
Dolecek, Christiane
van Doorn, H. Rogier
Guerin, Philippe J.
Day, Nicholas P. J.
Ashley, Elizabeth A.
author_sort Turner, Paul
collection PubMed
description BACKGROUND: There is a pressing need to understand better the extent and distribution of antimicrobial resistance on a global scale, to inform development of effective interventions. Collation of datasets for meta-analysis, mathematical modelling and temporo-spatial analysis is hampered by the considerable variability in clinical sampling, variable quality in laboratory practice and inconsistencies in antimicrobial susceptibility testing and reporting. METHODS: The Microbiology Investigation Criteria for Reporting Objectively (MICRO) checklist was developed by an international working group of clinical and laboratory microbiologists, infectious disease physicians, epidemiologists and mathematical modellers. RESULTS: In keeping with the STROBE checklist, but applicable to all study designs, MICRO defines items to be included in reports of studies involving human clinical microbiology data. It provides a concise and comprehensive reference for clinicians, researchers, reviewers and journals working on, critically appraising, and publishing clinical microbiology datasets. CONCLUSIONS: Implementation of the MICRO checklist will enhance the quality and scientific reporting of clinical microbiology data, increasing data utility and comparability to improve surveillance, grade data quality, facilitate meta-analyses and inform policy and interventions from local to global levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1301-1) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6440102
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-64401022019-04-11 Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data Turner, Paul Fox-Lewis, Andrew Shrestha, Poojan Dance, David A. B. Wangrangsimakul, Tri Cusack, Tomas-Paul Ling, Clare L. Hopkins, Jill Roberts, Tamalee Limmathurotsakul, Direk Cooper, Ben S. Dunachie, Susanna Moore, Catrin E. Dolecek, Christiane van Doorn, H. Rogier Guerin, Philippe J. Day, Nicholas P. J. Ashley, Elizabeth A. BMC Med Guideline BACKGROUND: There is a pressing need to understand better the extent and distribution of antimicrobial resistance on a global scale, to inform development of effective interventions. Collation of datasets for meta-analysis, mathematical modelling and temporo-spatial analysis is hampered by the considerable variability in clinical sampling, variable quality in laboratory practice and inconsistencies in antimicrobial susceptibility testing and reporting. METHODS: The Microbiology Investigation Criteria for Reporting Objectively (MICRO) checklist was developed by an international working group of clinical and laboratory microbiologists, infectious disease physicians, epidemiologists and mathematical modellers. RESULTS: In keeping with the STROBE checklist, but applicable to all study designs, MICRO defines items to be included in reports of studies involving human clinical microbiology data. It provides a concise and comprehensive reference for clinicians, researchers, reviewers and journals working on, critically appraising, and publishing clinical microbiology datasets. CONCLUSIONS: Implementation of the MICRO checklist will enhance the quality and scientific reporting of clinical microbiology data, increasing data utility and comparability to improve surveillance, grade data quality, facilitate meta-analyses and inform policy and interventions from local to global levels. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12916-019-1301-1) contains supplementary material, which is available to authorized users. BioMed Central 2019-03-29 /pmc/articles/PMC6440102/ /pubmed/30922309 http://dx.doi.org/10.1186/s12916-019-1301-1 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Guideline
Turner, Paul
Fox-Lewis, Andrew
Shrestha, Poojan
Dance, David A. B.
Wangrangsimakul, Tri
Cusack, Tomas-Paul
Ling, Clare L.
Hopkins, Jill
Roberts, Tamalee
Limmathurotsakul, Direk
Cooper, Ben S.
Dunachie, Susanna
Moore, Catrin E.
Dolecek, Christiane
van Doorn, H. Rogier
Guerin, Philippe J.
Day, Nicholas P. J.
Ashley, Elizabeth A.
Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title_full Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title_fullStr Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title_full_unstemmed Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title_short Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data
title_sort microbiology investigation criteria for reporting objectively (micro): a framework for the reporting and interpretation of clinical microbiology data
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6440102/
https://www.ncbi.nlm.nih.gov/pubmed/30922309
http://dx.doi.org/10.1186/s12916-019-1301-1
work_keys_str_mv AT turnerpaul microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT foxlewisandrew microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT shresthapoojan microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT dancedavidab microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT wangrangsimakultri microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT cusacktomaspaul microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT lingclarel microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT hopkinsjill microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT robertstamalee microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT limmathurotsakuldirek microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT cooperbens microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT dunachiesusanna microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT moorecatrine microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT dolecekchristiane microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT vandoornhrogier microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT guerinphilippej microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT daynicholaspj microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata
AT ashleyelizabetha microbiologyinvestigationcriteriaforreportingobjectivelymicroaframeworkforthereportingandinterpretationofclinicalmicrobiologydata